Guidelines for the testing and reporting of cytogenetic results for risk stratification of multiple myeloma: a report of the Cancer Genomics Consortium Plasma Cell Neoplasm Working Group
Abstract Fluorescence in situ hybridization (FISH) remains the gold-standard clinical assay to detect genetic abnormalities in multiple myeloma (MM). However, FISH panel design, use of conventional chromosome banding analysis and reporting practices have been reported to vary among laboratories. The...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2025-06-01
|
| Series: | Blood Cancer Journal |
| Online Access: | https://doi.org/10.1038/s41408-025-01286-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850207537718099968 |
|---|---|
| author | Xinyan Lu Erica F. Andersen Rahul Banerjee Celeste C. Eno Patrick R. Gonzales Shaji Kumar Angela M. Lager Patricia M. Miron Trevor Pugh Fabiola Quintero-Rivera Virginia C. Thurston Daynna J. Wolff Jian Zhao Rafael Fonseca Linda B. Baughn |
| author_facet | Xinyan Lu Erica F. Andersen Rahul Banerjee Celeste C. Eno Patrick R. Gonzales Shaji Kumar Angela M. Lager Patricia M. Miron Trevor Pugh Fabiola Quintero-Rivera Virginia C. Thurston Daynna J. Wolff Jian Zhao Rafael Fonseca Linda B. Baughn |
| author_sort | Xinyan Lu |
| collection | DOAJ |
| description | Abstract Fluorescence in situ hybridization (FISH) remains the gold-standard clinical assay to detect genetic abnormalities in multiple myeloma (MM). However, FISH panel design, use of conventional chromosome banding analysis and reporting practices have been reported to vary among laboratories. Therefore, standardization in FISH testing and reporting practices is needed to improve report clarity and avoid misinterpretation. The recommendations in this paper represent a consensus of our Cancer Genomics Consortium Plasma Cell Neoplasm Working Group, comprising a joint panel of cytogenetic laboratory directors and clinical investigators with expertise in the diagnosis, risk stratification, and treatment of multiple myeloma. Prior to developing these consensus recommendations, we performed a full literature review and conducted a survey of 102 oncologists to assess current variations and challenges in MM cytogenetic/FISH testing and reporting. Our guidelines establish best practices for the optimization of FISH panel selection, and recommendations for standardized reporting of cytogenetic results to align with the 2025 International Myeloma Society (IMS)/International Myeloma Working Group (IMWG) Updated Risk Stratification. |
| format | Article |
| id | doaj-art-a76a87407bd44fbc8957bf70c76b26de |
| institution | OA Journals |
| issn | 2044-5385 |
| language | English |
| publishDate | 2025-06-01 |
| publisher | Nature Publishing Group |
| record_format | Article |
| series | Blood Cancer Journal |
| spelling | doaj-art-a76a87407bd44fbc8957bf70c76b26de2025-08-20T02:10:30ZengNature Publishing GroupBlood Cancer Journal2044-53852025-06-0115111010.1038/s41408-025-01286-wGuidelines for the testing and reporting of cytogenetic results for risk stratification of multiple myeloma: a report of the Cancer Genomics Consortium Plasma Cell Neoplasm Working GroupXinyan Lu0Erica F. Andersen1Rahul Banerjee2Celeste C. Eno3Patrick R. Gonzales4Shaji Kumar5Angela M. Lager6Patricia M. Miron7Trevor Pugh8Fabiola Quintero-Rivera9Virginia C. Thurston10Daynna J. Wolff11Jian Zhao12Rafael Fonseca13Linda B. Baughn14Department of Pathology, Northwestern University Feinberg School of MedicineDepartment of Pathology, University of Utah, ARUP LaboratoriesDivision of Hematology and Oncology, University of WashingtonDepartment of Pathology and Laboratory Medicine, Cedars-Sinai Medical CenterDepartment of Pathology and Laboratory Medicine, University of Kansas Medical CenterDivision of Hematology, Mayo ClinicDepartment of Pathology, University of ChicagoDepartment of Pathology, UMass Memorial Health/UMass Chan Medical SchoolDepartment of Medical Biophysics, University of TorontoDepartments of Pathology, Laboratory Medicine, and Pediatrics, Division of Genetic and Genomic Medicine, University of California Irvine (UCI), UC Irvine HealthParke Cytogenetics, Advocate Health-Atrium Health and Carolinas PathologyDepartment of Pathology and Laboratory Medicine, Medical University of South CarolinaDepartment of Pathology, University of Utah, ARUP LaboratoriesDivision of Hematology and Medical Oncology, Mayo ClinicDivision of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo ClinicAbstract Fluorescence in situ hybridization (FISH) remains the gold-standard clinical assay to detect genetic abnormalities in multiple myeloma (MM). However, FISH panel design, use of conventional chromosome banding analysis and reporting practices have been reported to vary among laboratories. Therefore, standardization in FISH testing and reporting practices is needed to improve report clarity and avoid misinterpretation. The recommendations in this paper represent a consensus of our Cancer Genomics Consortium Plasma Cell Neoplasm Working Group, comprising a joint panel of cytogenetic laboratory directors and clinical investigators with expertise in the diagnosis, risk stratification, and treatment of multiple myeloma. Prior to developing these consensus recommendations, we performed a full literature review and conducted a survey of 102 oncologists to assess current variations and challenges in MM cytogenetic/FISH testing and reporting. Our guidelines establish best practices for the optimization of FISH panel selection, and recommendations for standardized reporting of cytogenetic results to align with the 2025 International Myeloma Society (IMS)/International Myeloma Working Group (IMWG) Updated Risk Stratification.https://doi.org/10.1038/s41408-025-01286-w |
| spellingShingle | Xinyan Lu Erica F. Andersen Rahul Banerjee Celeste C. Eno Patrick R. Gonzales Shaji Kumar Angela M. Lager Patricia M. Miron Trevor Pugh Fabiola Quintero-Rivera Virginia C. Thurston Daynna J. Wolff Jian Zhao Rafael Fonseca Linda B. Baughn Guidelines for the testing and reporting of cytogenetic results for risk stratification of multiple myeloma: a report of the Cancer Genomics Consortium Plasma Cell Neoplasm Working Group Blood Cancer Journal |
| title | Guidelines for the testing and reporting of cytogenetic results for risk stratification of multiple myeloma: a report of the Cancer Genomics Consortium Plasma Cell Neoplasm Working Group |
| title_full | Guidelines for the testing and reporting of cytogenetic results for risk stratification of multiple myeloma: a report of the Cancer Genomics Consortium Plasma Cell Neoplasm Working Group |
| title_fullStr | Guidelines for the testing and reporting of cytogenetic results for risk stratification of multiple myeloma: a report of the Cancer Genomics Consortium Plasma Cell Neoplasm Working Group |
| title_full_unstemmed | Guidelines for the testing and reporting of cytogenetic results for risk stratification of multiple myeloma: a report of the Cancer Genomics Consortium Plasma Cell Neoplasm Working Group |
| title_short | Guidelines for the testing and reporting of cytogenetic results for risk stratification of multiple myeloma: a report of the Cancer Genomics Consortium Plasma Cell Neoplasm Working Group |
| title_sort | guidelines for the testing and reporting of cytogenetic results for risk stratification of multiple myeloma a report of the cancer genomics consortium plasma cell neoplasm working group |
| url | https://doi.org/10.1038/s41408-025-01286-w |
| work_keys_str_mv | AT xinyanlu guidelinesforthetestingandreportingofcytogeneticresultsforriskstratificationofmultiplemyelomaareportofthecancergenomicsconsortiumplasmacellneoplasmworkinggroup AT ericafandersen guidelinesforthetestingandreportingofcytogeneticresultsforriskstratificationofmultiplemyelomaareportofthecancergenomicsconsortiumplasmacellneoplasmworkinggroup AT rahulbanerjee guidelinesforthetestingandreportingofcytogeneticresultsforriskstratificationofmultiplemyelomaareportofthecancergenomicsconsortiumplasmacellneoplasmworkinggroup AT celesteceno guidelinesforthetestingandreportingofcytogeneticresultsforriskstratificationofmultiplemyelomaareportofthecancergenomicsconsortiumplasmacellneoplasmworkinggroup AT patrickrgonzales guidelinesforthetestingandreportingofcytogeneticresultsforriskstratificationofmultiplemyelomaareportofthecancergenomicsconsortiumplasmacellneoplasmworkinggroup AT shajikumar guidelinesforthetestingandreportingofcytogeneticresultsforriskstratificationofmultiplemyelomaareportofthecancergenomicsconsortiumplasmacellneoplasmworkinggroup AT angelamlager guidelinesforthetestingandreportingofcytogeneticresultsforriskstratificationofmultiplemyelomaareportofthecancergenomicsconsortiumplasmacellneoplasmworkinggroup AT patriciammiron guidelinesforthetestingandreportingofcytogeneticresultsforriskstratificationofmultiplemyelomaareportofthecancergenomicsconsortiumplasmacellneoplasmworkinggroup AT trevorpugh guidelinesforthetestingandreportingofcytogeneticresultsforriskstratificationofmultiplemyelomaareportofthecancergenomicsconsortiumplasmacellneoplasmworkinggroup AT fabiolaquinterorivera guidelinesforthetestingandreportingofcytogeneticresultsforriskstratificationofmultiplemyelomaareportofthecancergenomicsconsortiumplasmacellneoplasmworkinggroup AT virginiacthurston guidelinesforthetestingandreportingofcytogeneticresultsforriskstratificationofmultiplemyelomaareportofthecancergenomicsconsortiumplasmacellneoplasmworkinggroup AT daynnajwolff guidelinesforthetestingandreportingofcytogeneticresultsforriskstratificationofmultiplemyelomaareportofthecancergenomicsconsortiumplasmacellneoplasmworkinggroup AT jianzhao guidelinesforthetestingandreportingofcytogeneticresultsforriskstratificationofmultiplemyelomaareportofthecancergenomicsconsortiumplasmacellneoplasmworkinggroup AT rafaelfonseca guidelinesforthetestingandreportingofcytogeneticresultsforriskstratificationofmultiplemyelomaareportofthecancergenomicsconsortiumplasmacellneoplasmworkinggroup AT lindabbaughn guidelinesforthetestingandreportingofcytogeneticresultsforriskstratificationofmultiplemyelomaareportofthecancergenomicsconsortiumplasmacellneoplasmworkinggroup |